QUICK DISSOLVING DIPHENHYDRAMINE ORAL DOSAGE FORM

An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The...

Full description

Saved in:
Bibliographic Details
Main Authors Richard John DANSEREAU, Erin Nicole SWIGART, Brian LASTER, Ashraf TRABOULSI
Format Patent
LanguageEnglish
Spanish
Published 09.11.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes. Una forma de dosificación por vía oral para suministrar difenhidramina a través de la mucosa sublingual o bucal. La forma de dosificación por vía oral puede contener difenhidramina, o una sal farmacéuticamente aceptable de esta, un potenciador de la permeabilidad y un agente regulador. El agente regulador puede lograr un pH de aproximadamente 7.0 a aproximadamente 8.0. La difenhidramina puede disolverse totalmente en aproximadamente 2 minutos.
Bibliography:Application Number: MX20180007440